Back to Screener

Healthcare

Cardiff Oncology, Inc.(CRDF)

Live Price

Offline

$1.21

+2.54% today

1Y Change

-59.35%

Window

Jun 25, 2025 โ†’ Jun 24, 2026

Market Cap
$110.00M
Revenue Growth
-13.2%
EPS Growth
+27.4%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 25, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Cardiff Oncology, Inc. (CRDF) is a Healthcare stock with a market cap of $110.00M and listed on NASDAQ. The stock last traded around $1.21 and down 59.4% across the available one-year price window (Jun 25, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of -13.2%, EPS growth of +27.4%, a dividend yield of 0.0%. What stands out right now is revenue -13.2%, EPS +27.4%, free cash flow -0.5% with operating margin -8256.3% and ROIC -105.9%. Valuation already assumes a fairly strong business story at price/sales 185.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CRDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CRDF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CRDF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CRDF Max Drawdown

-73.48%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CRDF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -0.13
โ€”
โ€”
Est 95.7B
โ€”
May 14
โ€”
Feb 24, 26
โœ“
-0.11
Est -0.18
+38.9%
243.0B
Est 103.5B
+134.8%
Feb 24
โ€”
Nov 6, 25
โœ“
-0.17
Est -0.20
+15.0%
120.0B
Est 103.5B
+15.9%
Nov 6
โ€”
Jul 29, 25
โœ—
-0.21
Est -0.19
-10.5%
121.0B
Est 109.4B
+10.6%
Jul 29
โ€”
May 8, 25
โœ—
-0.20
Est -0.19
-5.3%
109.0B
Est 89.3B
+22.1%
May 8
โ€”
Feb 27, 25
โœ“
-0.21
Est -0.26
+19.2%
151.0B
Est 94.2B
+60.4%
Feb 27
โ€”
Nov 7, 24
โœ“
-0.25
Est -0.27
+7.4%
165.0B
Est 70.0B
+135.7%
Nov 7
โ€”
Aug 8, 24
โœ—
-0.26
Est -0.25
-4.0%
163.0B
Est 60.0B
+171.7%
Aug 8
โ€”
May 2, 24
โœ“
-0.22
Est -0.25
+12.0%
205.0B
Est 70.0B
+192.9%
May 2
โ€”
Feb 29, 24
โœ“
-0.21
Est -0.26
+19.2%
156.0B
Est 40.0B
+290.0%
Feb 29
โ€”
Nov 2, 23
โœ“
-0.22
Est -0.29
+24.1%
141.0B
Est 40.0B
+252.5%
Nov 2
โ€”
Aug 9, 23
โœ“
-0.25
Est -0.27
+7.4%
108.0B
Est 40.0B
+170.0%
Aug 9
โ€”
May 4, 23
โœ—
-0.25
Est -0.23
-8.7%
83.0B
Est 60.0B
+38.3%
May 4
โ€”
Mar 2, 23
โœ“
-0.20
Est -0.25
+20.0%
128.0B
Est 73.3B
+74.7%
Mar 2
โ€”
Nov 3, 22
โœ“
-0.20
Est -0.27
+25.9%
93.0B
Est 68.2B
+36.4%
Nov 3
โ€”
Aug 4, 22
โœ“
-0.24
Est -0.25
+4.0%
91.0B
Est 93.0B
-2.1%
Aug 4
โ€”
May 5, 22
โœ—
-0.25
Est -0.23
-8.7%
74.0B
Est 56.6B
+30.7%
May 5
โ€”
Feb 24, 22
โœ—
-0.23
Est -0.17
-35.3%
133.0B
Est 41.0B
+224.4%
Feb 24
โ€”
Nov 4, 21
โ€”
-0.17
Est -0.17
0.0%
86.0B
Est 30.0B
+186.7%
Nov 4
โ€”
Aug 5, 21
โœ—
-0.17
Est -0.15
-13.3%
68.0B
Est 150.0B
-54.7%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener